查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2067775

全球製藥流體處理市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Pharmaceutical Fluid Handling Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 324 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球醫藥流體處理市場預計將從2025年的170.1億美元成長至2034年的262億美元，2026年至2034年的複合年成長率（CAGR）為4.92%。該市場正經歷強勁成長，主要得益於醫藥生產活動的擴張以及對無菌和無污染生產流程日益成長的需求。流體處理系統在醫藥原料和製劑的轉移、儲存、混合和加工過程中發揮著至關重要的作用。生物製藥製造、疫苗生產和先進藥物研發領域投資的增加正在推動市場需求。此外，嚴格的產品品質和安全監管標準也進一步促進了市場應用。

製造商正日益採用先進的流體處理技術來提高製程效率並確保符合監管要求。一次性系統、自動化輸送解決方案和高純度流體管理系統在製藥企業中越來越普及。生物製藥和個人化藥物生產的擴張為專業流體處理解決方案創造了更多機會。這些趨勢正在推動全球製藥業的市場成長。

隨著製藥公司不斷擴大產能，預計未來市場將保持強勁成長。專注於自動化、製程監控和污染控制的技術創新將提升營運效率。在新興市場，對醫療基礎設施和製藥生產的投資增加正在創造新的機會。對生物製藥和先進治療方法的持續需求將支撐市場的永續發展。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：本節詳細評估影響市場成長的主要促進因素、限制因素、機會和挑戰。內容涵蓋技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長地區和區域趨勢，以更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球製藥流體處理市場：依產品/服務分類

  • 市場分析、洞察與預測
  • 設備和解決方案
  • 服務

第5章 全球製藥流體處理市場：依管材類型分類

  • 市場分析、洞察與預測
  • 熱可塑性橡膠
  • 聚氯乙烯
  • 矽酮

第6章 全球製藥流體處理市場：依應用領域分類

  • 市場分析、洞察與預測
  • 止咳糖漿
  • 靜脈注射準備
  • 複雜的藥物活性成分
  • 其他用途

第7章 全球製藥流體處理市場：依應用領域分類

  • 市場分析、洞察與預測
  • 流體處理與管理
  • 液體製備
  • 整合與自動化
  • 緩衝區管理
  • 其他用途

第8章 全球製藥流體處理市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 生技公司
  • 製藥和醫療公司
  • 其他最終用戶

第9章 全球製藥流體處理市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Pfizer Inc
    • Johnson & Johnson Pvt. Ltd
    • F. Hoffmann-La Roche AG
    • Merck & Co. Inc
    • AbbVie Inc
    • Thermo Fisher Scientific Inc
    • GlaxoSmithKline Plc
    • Danaher Corporation
    • Gilead Sciences Inc
    • Amgen Inc
    • Parker Hannifin Corporation
    • Corning Incorporated
    • Agilent Technologies Inc
    • Alfa Laval AB
    • PerkinElmer Inc
簡介目錄
Product Code: VMR112110575

The global pharmaceutical fluid handling market size is expected to reach USD 26.20 Billion in 2034 from USD 17.01 Billion in 2025, growing at a CAGR of 4.92 during 2026-2034.This market is experiencing strong growth due to increasing pharmaceutical production activities and rising demand for sterile and contamination-free manufacturing processes. Fluid handling systems play a critical role in the transfer, storage, mixing, and processing of pharmaceutical ingredients and formulations. Growing investments in biopharmaceutical manufacturing, vaccine production, and advanced drug development are driving market demand. Strict regulatory standards related to product quality and safety are further supporting adoption.

Manufacturers are increasingly implementing advanced fluid handling technologies to improve process efficiency and ensure compliance with regulatory requirements. Single-use systems, automated transfer solutions, and high-purity fluid management equipment are gaining popularity across pharmaceutical facilities. The expansion of biologics and personalized medicine production is creating additional opportunities for specialized fluid handling solutions. These trends are strengthening market growth across global pharmaceutical operations.

Future growth is expected to remain robust as pharmaceutical companies continue expanding production capacities. Technological innovations focused on automation, process monitoring, and contamination control will enhance operational efficiency. Emerging markets are witnessing rising investments in healthcare infrastructure and pharmaceutical manufacturing, creating new opportunities. Continued demand for biologics and advanced therapies will support sustained market development.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Offering

  • Equipment and Solutions
  • Services

By Tubing

  • Thermoplastic Elastomers
  • Polyvinyl Chloride
  • Silicone

By Usage

  • Cough Syrup
  • Intravenous Product
  • Complex Active Pharmaceutical Ingredients
  • Other Usage

By Application

  • Fluid Handling and Management
  • Fluid Preparation
  • Integration and Automation
  • Buffer Management
  • Other Applications

By End User

  • Biotechnology Companies
  • Pharmaceutical and Medical Companies
  • Other End Users

COMPANIES PROFILED

  • Pfizer Inc., Johnson & Johnson Pvt. Ltd., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Danaher Corporation, Gilead Sciences Inc., Amgen Inc., Parker Hannifin Corporation, Corning Incorporated, Agilent Technologies Inc., Alfa Laval AB, PerkinElmer Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHARMACEUTICAL FLUID HANDLING MARKET: BY OFFERING 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Offering
  • 4.2. Equipment and Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHARMACEUTICAL FLUID HANDLING MARKET: BY TUBING 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Tubing
  • 5.2. Thermoplastic Elastomers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Polyvinyl Chloride Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Silicone Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHARMACEUTICAL FLUID HANDLING MARKET: BY USAGE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Usage
  • 6.2. Cough Syrup Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Intravenous Product Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Complex Active Pharmaceutical Ingredients Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Other Usage Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHARMACEUTICAL FLUID HANDLING MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Application
  • 7.2. Fluid Handling and Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Fluid Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Integration and Automation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Buffer Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PHARMACEUTICAL FLUID HANDLING MARKET: BY END USER 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End User
  • 8.2. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Pharmaceutical and Medical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PHARMACEUTICAL FLUID HANDLING MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Offering
    • 9.2.2 By Tubing
    • 9.2.3 By Usage
    • 9.2.4 By Application
    • 9.2.5 By End User
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Offering
    • 9.3.2 By Tubing
    • 9.3.3 By Usage
    • 9.3.4 By Application
    • 9.3.5 By End User
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Offering
    • 9.4.2 By Tubing
    • 9.4.3 By Usage
    • 9.4.4 By Application
    • 9.4.5 By End User
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Offering
    • 9.5.2 By Tubing
    • 9.5.3 By Usage
    • 9.5.4 By Application
    • 9.5.5 By End User
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Offering
    • 9.6.2 By Tubing
    • 9.6.3 By Usage
    • 9.6.4 By Application
    • 9.6.5 By End User
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL PHARMACEUTICAL FLUID HANDLING INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Pfizer Inc
    • 11.2.2 Johnson & Johnson Pvt. Ltd
    • 11.2.3 F. Hoffmann-La Roche AG
    • 11.2.4 Merck & Co. Inc
    • 11.2.5 AbbVie Inc
    • 11.2.6 Thermo Fisher Scientific Inc
    • 11.2.7 GlaxoSmithKline Plc
    • 11.2.8 Danaher Corporation
    • 11.2.9 Gilead Sciences Inc
    • 11.2.10 Amgen Inc
    • 11.2.11 Parker Hannifin Corporation
    • 11.2.12 Corning Incorporated
    • 11.2.13 Agilent Technologies Inc
    • 11.2.14 Alfa Laval AB
    • 11.2.15 PerkinElmer Inc